TMEM206 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.007000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.651600E-02
Normal-vs-Stage2
1.234980E-01
Normal-vs-Stage3
1.306140E-02
Normal-vs-Stage4
1.254320E-02
Stage1-vs-Stage2
6.006200E-01
Stage1-vs-Stage3
1.542390E-01
Stage1-vs-Stage4
6.350000E-01
Stage2-vs-Stage3
6.219700E-02
Stage2-vs-Stage4
4.104600E-01
Stage3-vs-Stage4
3.243800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.021000E-01
Normal-vs-AfricanAmerican
3.740500E-03
Normal-vs-Asian
6.191800E-02
Caucasian-vs-AfricanAmerican
4.328600E-01
Caucasian-vs-Asian
6.038200E-01
AfricanAmerican-vs-Asian
3.630600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.627600E-02
Normal-vs-Female
1.315180E-01
Male-vs-Female
8.493200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.023700E-02
Normal-vs-Age(41-60Yrs)
2.164400E-01
Normal-vs-Age(61-80Yrs)
7.776000E-02
Normal-vs-Age(81-100Yrs)
4.915800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.674400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.106200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.601800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.926420E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.754800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.117200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.289600E-02
Normal-vs-Daily Drinker
4.763900E-03
Normal-vs-Weekly Drinker
1.596760E-01
Normal-vs-Occasional Drinker
2.371600E-01
Normal-vs-Social Drinker
7.579700E-02
Non Drinker-vs-Daily Drinker
1.518760E-01
Non Drinker-vs-Weekly Drinker
2.810200E-01
Non Drinker-vs-Occasional Drinker
1.035550E-01
Non Drinker-vs-Social Drinker
4.023400E-01
Daily Drinker-vs-Weekly Drinker
8.513600E-02
Daily Drinker-vs-Occasional Drinker
9.304900E-03
Daily Drinker-vs-Social Drinker
4.931900E-02
Weekly Drinker-vs-Occasional Drinker
8.919600E-01
Weekly Drinker-vs-Social Drinker
5.590200E-01
Occasional Drinker-vs-Social Drinker
4.968600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.657200E-01
Normal-vs-Grade 2
9.144400E-01
Normal-vs-Grade 3
9.208000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.603200E-01
Grade 1-vs-Grade 3
2.789400E-01
Grade 1-vs-Grade 4
8.657200E-01
Grade 2-vs-Grade 3
8.629800E-01
Grade 2-vs-Grade 4
9.144400E-01
Grade 3-vs-Grade 4
9.208000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.80420000000159E-05
Normal-vs-NonDiabetic
7.416100E-02
Diabetic-vs-NonDiabetic
6.266800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.594200E-02
Normal-vs-NoPancreatitis
9.957900E-02
Pancreatitis-vs-NoPancreatitis
9.850200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.525800E-02
Normal-vs-N1
1.162350E-01
N0-vs-N1
8.579000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.59419999995669E-06
Normal-vs-TP53-NonMutant
1.82089999967161E-07
TP53-Mutant-vs-TP53-NonMutant
1.871230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
